Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StromaForte in Aging Frailty
NCT06070532Phase 2Not yet recruiting
- Sponsor
- Cellcolabs
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of StromaForte in frailty syndrome, sponsored by Cellcolabs. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
StromaForte
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT06070532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06070532.